Results 141 to 150 of about 63,206 (209)

Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis. [PDF]

Sci Rep
Sattayalertyanyong O, Bandidniyamanon W, Limsrivilai J, Chotiyaputta W, Nimanong S, Tanwandee T.   +5 more
europepmc   +1 more source

Virologic, immunologic, and metabolic outcomes and mortality in people with HIV on bictegravir/emtricitabine/tenofovir alafenamide fumarate versus dolutegravir-based antiretroviral therapies: a retrospective multicenter cohort study in China. [PDF]

Lancet Reg Health West Pac
Wu X, Ma P, Ruan L, Chen Y, Wang R, Song Y, Cai Y, Chen F, Zhang L, Fitzpatrick T, Li B, Wu G, Meng X, Fan S, Qiao Y, Gao Y, Hong Z, Zhang T, Zou M, Wang L, Fu Y, Su B, Zou J, Wang H, Zou H.   +24 more
europepmc   +1 more source

Lenacapavir as pre-exposure prophylaxis for HIV prevention. [PDF]

Cochrane Database Syst Rev
Ebrahim S, Gloeck N, Adam Z, Tatz G, Nel J, Sinxadi PZ, Dawood H, Kredo T, Cohen K.   +8 more
europepmc   +1 more source

Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies. [PDF]

J Infect Dis
Cox S, Andreatta K, Hendricks MR, Li J, Kintu A, Brown LB, Carter CC, Callebaut C.   +7 more
europepmc   +1 more source

Combined tenofovir, lamivudine, and dolutegravir treatment increases leptin and FABP4 expression in human subcutaneous adipose tissue. [PDF]

Einstein (Sao Paulo)
Zanardo LW, Izabel LDS, Hamada LM, Carvalho MB, Silva PAGOE, Joaquim HDG, Santoro S, Festuccia WT, Magdalon J.   +8 more
europepmc   +1 more source

Healthcare Resource Consumption and Related Costs of People Living with HIV and Antiviral Treatment: A Retrospective Observational Study in Italy. [PDF]

Diseases
Degli Esposti L, Mazzoni S, Cappuccilli M, Maggiolo F, Caputo SL, Nozza S, Taramasso L, Marra A, Pittorru M.   +8 more
europepmc   +1 more source

Tenofovir vs. entecavir in chronic hepatitis B: A retrospective cohort study of hepatocellular carcinoma risk in a tertiary hospital in southern Brazil. [PDF]

Braz J Infect Dis
Stamm AN, Tovo CV, Noal A, Silva CU, Pizzi J, Fonseca PM, Kliemann DA.   +6 more
europepmc   +1 more source

Switch to Fixed Dose of Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate Versus Bictegravir, Emtricitabine, and Tenofovir Alafenamide Fumarate in Virologically Suppressed Adults on Efavirenz-Based Regimens: 48-Week Results of a Real-world, Prospective, Observational Cohort Study. [PDF]

Open Forum Infect Dis
Li A, Li Z, Li J, Gao Y, Dai L, Liu A, Zhang H, Wang X, Wu L, Yao Y, Liu L, Ye J, Sun L.   +12 more
europepmc   +1 more source

Clinical and biological risk factors influencing infant HIV status: a case study of Kisenyi Health Center IV, Kampala, Uganda. [PDF]

BMC Infect Dis
Bagonza FX, Asiimwe JB, Wamono F, Nsimbe D.   +3 more
europepmc   +1 more source

Dapagliflozin treatment ameliorates oxidative stress, apoptosis and inflammation in tenofovir-induced nephrotoxicity in rats. [PDF]

Sci Rep
Dos Santos VA, Viotto ACR, Nascimento MM, Bernardo DRD, Shimizu MHM, de Sena CR, Seguro AC, Volpini RA, de Bragança AC, Canale D.   +9 more
europepmc   +1 more source